CAS: 54631-81-1; Boc-Hyp(Bzl)-Oh

该化合物是氨酸分泌的衍生物,其特点是存在一种乙基-丁基氧碳基(Boc)保护组和一个与氢氧基(Hydzyl)附属的苯基组,该化合物通常用于peptide合成,并因其在化学反应中能够保护功能组,而作为有机合成的中间体.Boc组是该矿的防护组,允许有选择地作出反应,而不会干扰氨基功能.苯基组增强了分子的脂性,可影响其溶性和再活性.在标准实验室条件下,乙基-O-苯-L-氢氧丙酸丙酸丙酯一般稳定,但可能需要有具体的保护条件或进一步反应.其结构特征有助于其在更复杂的分子合成中的效用,特别是在医药化学和药物开发领域.

结构式图片

上下游产品

(2S,4S)-1-tert-butyl 2-methyl 4-(benzyloxy)pyrrolidine-1,2-dicarboxylate (2S,4S)-2-benzyl 1-tert-butyl 4-(benzyloxy)pyrrolidine-1,2-dicarboxylate benzyl bromide N-tert-butoxycarbonyl-L-cis-4-hydroxyproline4(S)-Benzyloxy-N-tert-butyl-1-(tert-butyloxycarbonyl) pyrrolidine-2(S)-carboxamide Thr-Homotyr-4-OH-Pro-Thr-α-N-(°Ctyloxybenzpyl)-Orn Thr-Thr-Homotyr-Pro-Thr-α-N-(°Ctyloxybenzoyl)-Orn Pro-Thr-Tyr-4-OH-Pro-Thr-α-N-(°Ctyloxybenzoyl)-Orn

合成工艺路线路线简述

    📜N-Boc-反式-4-羟基-L-脯氨酸甲酯置于水,Sodium Hydride,Sodium Hydroxide体系中,用 四氢呋喃,甲醇,Hexanes,N,N-二甲基甲酰胺 作为反应溶剂,化学反应 2.17H,反应生成 N-叔丁氧羰基-O-苄基-反式-4-羟基-L-脯氨酸
    参考文献: Pyrrolotriazinone Derivatives As Pi3K Inhibitors[fr] Dérivés De Pyrrolotriazinone En Tant Qu'Inhibiteurs De Pi3K
    标题: Pyrrolotriazinone Derivatives As Pi3K Inhibitors[fr] Dérivés De Pyrrolotriazinone En Tant Qu'Inhibiteurs De Pi3K
    摘要:披露了具有公式(I)化学结构的新型吡咯三嗪酮衍生物;以及它们的制备方法,包含它们的药物组合物以及它们作为磷脂酰肌醇3-激酶(pi3Ks)抑制剂在治疗中的用途.

    海关参考信息

    专利信息


    专利号:US-2004110228-A1
    优先权日:2002-04-01
    标 题:Combinatorial organic synthesis of unique biologically active compounds
    发明人:MCALPINE SHELLI R; TAYLOR RACHEL E; BOLLA MEGAN L; SEGALL ANCA M
    摘要:The invention provides a method for making a combinatorial library of cyclic compounds, such as Holliday junction-trapping compounds, comprising the steps of (a) obtaining a plurality of trimers according to the generic structure X 1- X 2- X 3 , wherein X 1 , X 2 and X 3 can be independently any naturally or nonnaturally occurring amino acids or peptidomimetics thereof; (b) optionally coupling a spacer S to the trimer at either end; (c) cyclizing two trimers or trimer-spacer conjugates in a head-to-tail orientation; thereby obtaining a combinatorial library of compounds, wherein the library does not include an unmodifed or naturally occurring Holliday Junction-trapping compounds. The invention additionally provides methods macrocyclic compounds that are synergimycin derivatives.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1007/978-94-010-9060-5_165
    摘要:Leplawy MT, Kociolek K, Redlinski AS, Slomczynska U, Zabrocki J, Dunbar JB, Marshall GR. Chemical-enzymatic synthesis of emerimicin IV and III, membrane-active pentadecapeptide antibiotics. 1990. In: Peptides.
    参考文献:10.1055/s-2005-870026
    摘要:Kokotos G, Bellis E, Vasilatou K. 4-Substituted Prolyl Sulfonamides as Enantioselective Organocatalysts for Aldol Reactions. Synthesis. 2005;(14):2407–13. doi: 10.1055/s-2005-870026.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知